216 related articles for article (PubMed ID: 15579053)
1. Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome.
Evangelista S
Curr Pharm Des; 2004; 10(28):3561-8. PubMed ID: 15579053
[TBL] [Abstract][Full Text] [Related]
2. Role of antispasmodics in the treatment of irritable bowel syndrome.
Annaházi A; Róka R; Rosztóczy A; Wittmann T
World J Gastroenterol; 2014 May; 20(20):6031-43. PubMed ID: 24876726
[TBL] [Abstract][Full Text] [Related]
3. The use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromide.
Forte E; Pizzoferrato M; Lopetuso L; Scaldaferri F
Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):25-37. PubMed ID: 22338545
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the action of otilonium bromide and pinaverium bromide: study conducted under clinical control.
Defrance P; Casini A
Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):64-6. PubMed ID: 1756286
[TBL] [Abstract][Full Text] [Related]
5. Otilonium bromide: a selective spasmolytic for the gastrointestinal tract.
Evangelista S
J Int Med Res; 1999; 27(5):207-22. PubMed ID: 10689627
[TBL] [Abstract][Full Text] [Related]
6. Antimuscarinic, calcium channel blocker and tachykinin NK2 receptor antagonist actions of otilonium bromide in the circular muscle of guinea-pig colon.
Santicioli P; Zagorodnyuk V; Renzetti AR; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1999 May; 359(5):420-7. PubMed ID: 10498293
[TBL] [Abstract][Full Text] [Related]
7. Action of pinaverium bromide, a calcium-antagonist, on gastrointestinal motility disorders.
Christen MO
Gen Pharmacol; 1990; 21(6):821-5. PubMed ID: 2177709
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of irritable bowel syndrome with dicetelium and spasmomen].
Nedogoda SV; Parshev VV
Klin Med (Mosk); 2000; 78(10):42-6. PubMed ID: 11220900
[TBL] [Abstract][Full Text] [Related]
9. Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study.
Battaglia G; Morselli-Labate AM; Camarri E; Francavilla A; De Marco F; Mastropaolo G; Naccarato R
Aliment Pharmacol Ther; 1998 Oct; 12(10):1003-10. PubMed ID: 9798806
[TBL] [Abstract][Full Text] [Related]
10. Double-blind study of a new antimuscarinic, cimetropium bromide, in patients with irritable bowel syndrome.
Ferrari A; Cavallero M; Spandre M; Gemme C; Rossini FP; Imbimbo BP
Clin Ther; 1986; 8(3):320-8. PubMed ID: 3521859
[TBL] [Abstract][Full Text] [Related]
11. [The clinical pharmacological profile of pinaverium bromide].
Guslandi M
Minerva Med; 1994 Apr; 85(4):179-85. PubMed ID: 8028745
[TBL] [Abstract][Full Text] [Related]
12. Irritable bowel syndrome: focus on otilonium bromide.
Boeckxstaens G; Clavé P; Corazziari ES; Tack J
Expert Rev Gastroenterol Hepatol; 2014 Feb; 8(2):131-7. PubMed ID: 24417261
[TBL] [Abstract][Full Text] [Related]
13. IBS and the role of otilonium bromide.
Boeckxstaens G; Corazziari ES; Mearin F; Tack J
Int J Colorectal Dis; 2013 Mar; 28(3):295-304. PubMed ID: 23178991
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Toxicity Due to Otilonium Bromide Overdose: A Case Report.
Zaki SA; Helal ME; Rashid A
J Emerg Med; 2022 Mar; 62(3):e47-e50. PubMed ID: 35031171
[TBL] [Abstract][Full Text] [Related]
15. Irritable bowel syndrome.
Spinelli A
Clin Drug Investig; 2007; 27(1):15-33. PubMed ID: 17177577
[TBL] [Abstract][Full Text] [Related]
16. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
Clavé P; Acalovschi M; Triantafillidis JK; Uspensky YP; Kalayci C; Shee V; Tack J;
Aliment Pharmacol Ther; 2011 Aug; 34(4):432-42. PubMed ID: 21679214
[TBL] [Abstract][Full Text] [Related]
17. Otilonium Bromide: A Drug with a Complex Mechanism of Action.
Evangelista S; Traini C; Vannucchi MG
Curr Pharm Des; 2018; 24(16):1772-1779. PubMed ID: 29732965
[TBL] [Abstract][Full Text] [Related]
18. A Mini Review on Characteristics and Analytical Methods of Otilonium Bromide.
Shrivastava A; Mittal A
Crit Rev Anal Chem; 2022; 52(7):1717-1725. PubMed ID: 34039224
[TBL] [Abstract][Full Text] [Related]
19. Otilonium bromide inhibits calcium entry through L-type calcium channels in human intestinal smooth muscle.
Strege PR; Evangelista S; Lyford GL; Sarr MG; Farrugia G
Neurogastroenterol Motil; 2004 Apr; 16(2):167-73. PubMed ID: 15086870
[TBL] [Abstract][Full Text] [Related]
20. Is otilonium bromide globally effective in irritable bowel syndrome?
Desborough MJ; Ford AC
Aliment Pharmacol Ther; 2011 Oct; 34(8):1034-5; author reply 1035-6. PubMed ID: 21933208
[No Abstract] [Full Text] [Related]
[Next] [New Search]
